Home > Healthcare > Healthcare IT > Payer/Provider Solutions > digital wound measurement devices market
Get a free sample of Digital Wound Measurement Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Digital Wound Measurement Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The digital wound measurement devices industry is consolidated in nature, with major companies competing to offer superior digital wound measurement devices in this business space. Prominent players such as Kent Imaging Inc., ARANZ Medical Limited, and TISSUE ANALYTICS hold a significant share in this market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share.
Some of the eminent market participants operating in the digital wound measurement devices industry include:
The chronic wound type segment held over 70.3% of the market in 2022 and is anticipated to gain traction up to 2032 owing to the ongoing need for therapy and monitoring.
Digital wound measurement devices industry size was USD 75.7 million in 2022 and may reach USD 135 million by 2032 due to the increasing incidence of chronic wounds, including diabetic ulcers, pressure ulcers, and venous ulcers.
The 3D technology segment garnered over 74% share of the digital wound measurement devices industry in 2022 and is anticipated to witness immense traction through 2032 driven by higher adoption for more precise and accurate wound measurements.
North America digital wound measurement devices industry size crossed USD 30 million in 2022 and is predicted to record substantial growth through 2032 due to relatively high prevalence of chronic diseases, such as diabetes and obesity.